Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis.
Nanna B. Finnerup,Nadine Attal,Simon Haroutounian,Ewan D McNicol,Ralf Baron,Robert H. Dworkin,Ian Gilron,Maija Haanpää,Per Hansson,Per Hansson,Troels S. Jensen,Troels S. Jensen,Peter R. Kamerman,Karen Lund,Andrew Moore,Srinivasa N. Raja,Andrew S.C. Rice,Andrew S.C. Rice,Michael C. Rowbotham,Emily S. Sena,Emily S. Sena,Philip J. Siddall,Philip J. Siddall,Blair H. Smith,Mark S. Wallace +24 more
Reads0
Chats0
TLDR
The results support a revision of the NeuPSIG recommendations for the pharmacotherapy of neuropathic pain and allow a strong recommendation for use and proposal as first-line treatment in neuropathicPain for tricyclic antidepressants, serotonin-noradrenaline reuptake inhibitors, pregabalin, and gabapentin.Abstract:
Summary Background New drug treatments, clinical trials, and standards of quality for assessment of evidence justify an update of evidence-based recommendations for the pharmacological treatment of neuropathic pain. Using the Grading of Recommendations Assessment, Development, and E valuation (GRADE), we revised the Special Interest Group on Neuropathic Pain (NeuPSIG) recommendations for the pharmacotherapy of neuropathic pain based on the results of a systematic review and meta-analysis. Methods Between April, 2013, and January, 2014, NeuPSIG of the International Association for the Study of Pain did a systematic review and meta-analysis of randomised, double-blind studies of oral and topical pharmacotherapy for neuropathic pain, including studies published in peer-reviewed journals since January , 1966, and unpublished trials retrieved from ClinicalTrials.gov and websites of pharmaceutical companies. We used number needed to treat (NNT) for 50% pain relief as a primary measure and assessed publication bias; NNT was calculated with the fi xed-eff ects Mantel-Haenszel method. Findings 229 studies were included in the meta-analysis. Analysis of publication bias suggested a 10% overstatement of treatment eff ects. Studies published in peer-reviewed journals reported greater eff ects than did unpublished studies (r² 9·3%, p=0·009). T rial outcomes were generally modest: in particular, combined NNTs were 6·4 (95% CI 5·2–8·4) for serotonin-noradrenaline reuptake inhibitors, mainly including duloxetine (nine of 14 studies); 7·7 (6·5–9·4) for pregabalin; 7·2 (5·9–9·21) for gabapentin, including gabapentin extended release and enacarbil; and 10·6 (7·4–19·0) for capsaicin high-concentration patches. NNTs were lower for tricyclic antidepressants, strong opioids, tramadol, and botulinum toxin A, and undetermined for lidocaine patches. Based on GRADE, fi nal quality of evidence was moderate or high for all treatments apart from lidocaine patches; tolerability and safety, and values and preferences were higher for topical drugs; and cost was lower for tricyclic antidepressants and tramadol. These fi ndings permitted a strong recommendation for use and proposal as fi rst-line treatment in neuropathic pain for tricyclic antidepressants, serotonin-noradrenaline reuptake inhibitors, pregabalin, and gabapentin; a weak recommendation for use and proposal as second line for lidocaine patches, capsaicin high-concentration patches, and tramadol; and a weak recommendation for use and proposal as third line for strong opioids and botulinum toxin A. Topical agents and botulinum toxin A are recommended for peripheral neuropathic pain only. Interpretation Our results support a revision of the NeuPSIG recommendations for the pharmacotherapy of neuropathic pain. Inadequate response to drug treatments constitutes a substantial unmet need in patients with neuropathic pain. Modest effi cacy, large placebo responses, heterogeneous diagnostic criteria, and poor phenotypic profi ling probably account for moderate trial outcomes and should be taken into account in future studies. Funding NeuPSIG of the International Association for the Study of Pain.read more
Citations
More filters
Journal ArticleDOI
Combination pharmacotherapy for the treatment of neuropathic pain in adults: systematic review and meta-analysis.
Marielle Balanaser,Meg Carley,Ralf Baron,Nanna B. Finnerup,R Andrew Moore,Michael C. Rowbotham,Luis Enrique Chaparro,Ian Gilron +7 more
TL;DR: Combining different drugs sometimes provides improved analgesia and/or tolerability in adults with neuropathic pain, but convincing evidence has not yet emerged to suggest superiority of any combination over its respective monotherapies.
Journal ArticleDOI
Oligomerization of MrgC11 and μ-opioid receptors in sensory neurons enhances morphine analgesia
Shao Qiu He,Qian Xu,Vinod Tiwari,Fei Yang,Michael Anderson,Zhiyong Chen,Shaness A. Grenald,Srinivasa N. Raja,Xinzhong Dong,Yun Guan +9 more
TL;DR: The results uncover MrgC11-MOR interactions that lead to positive functional modulation of MOR and suggest that coactivating MrgX in patients may improve the use of opioids for treating pain.
Journal ArticleDOI
An Electroencephalography Bioassay for Preclinical Testing of Analgesic Efficacy
Suguru Koyama,Brian W. LeBlanc,Brian W. LeBlanc,Kelsey A. Smith,Kelsey A. Smith,Catherine Roach,Catherine Roach,Joshua Levitt,Joshua Levitt,Muhammad Muzzammil Edhi,Muhammad Muzzammil Edhi,Mai Michishita,Takayuki Komatsu,Okishi Mashita,Aki Tanikawa,Satoru Yoshikawa,Carl Y. Saab,Carl Y. Saab +17 more
TL;DR: It is suggested that EEG theta power can be used to detect false positive and false negative outcomes of the withdrawal reflex behavior, and novel insights into the analgesic effects of these drugs on spontaneous nociceptive states in rats are yielded.
Journal ArticleDOI
Potential inappropriate prescribing and associated factors among older persons in Nigeria and South Africa.
TL;DR: The prevalence and pattern of PIP among Nigerian and South African participants were similar and Hypertension was an associated factor for PIPamong the participants in both countries.
Journal ArticleDOI
Polygenic evidence and overlapped brain functional connectivities for the association between chronic pain and sleep disturbance.
Jie Sun,Wei Yan,Xing-Nan Zhang,Xiao Lin,Hui Li,Yimiao Gong,Xi-Mei Zhu,Yong-Bo Zheng,Xiang-Yang Guo,Yun-Dong Ma,Zeng-Yi Liu,Lin Liu,Jia-Hong Gao,Michael V. Vitiello,Suhua Chang,Suhua Chang,Xiao-Guang Liu,Lin Lu,Lin Lu +18 more
TL;DR: The results provided genetic and neural evidence for the association between pain and sleep disturbance, which may inform future treatment approaches for comorbid chronic pain states andSleep disturbance.
References
More filters
Journal ArticleDOI
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
TL;DR: Moher et al. as mentioned in this paper introduce PRISMA, an update of the QUOROM guidelines for reporting systematic reviews and meta-analyses, which is used in this paper.
Journal Article
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
TL;DR: The QUOROM Statement (QUality Of Reporting Of Meta-analyses) as mentioned in this paper was developed to address the suboptimal reporting of systematic reviews and meta-analysis of randomized controlled trials.
Journal ArticleDOI
Bias in meta-analysis detected by a simple, graphical test
TL;DR: Funnel plots, plots of the trials' effect estimates against sample size, are skewed and asymmetrical in the presence of publication bias and other biases Funnel plot asymmetry, measured by regression analysis, predicts discordance of results when meta-analyses are compared with single large trials.
Journal ArticleDOI
Assessing the quality of reports of randomized clinical trials : is blinding necessary?
Alejandro R. Jadad,R. A. Moore,Dawn Carroll,C. Jenkinson,David Reynolds,David J. Gavaghan,Henry J McQuay +6 more
TL;DR: An instrument to assess the quality of reports of randomized clinical trials (RCTs) in pain research is described and its use to determine the effect of rater blinding on the assessments of quality is described.
Journal ArticleDOI
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Gordon H. Guyatt,Andrew D Oxman,Gunn Elisabeth Vist,Regina Kunz,Yngve Falck-Ytter,Pablo Alonso-Coello,Holger J. Schünemann +6 more
TL;DR: The advantages of the GRADE system are explored, which is increasingly being adopted by organisations worldwide and which is often praised for its high level of consistency.